SolidWorld Group: the Electrospider bioprinter shipped to a prestigious Swiss hospital

Treviso,3 December 2024– SolidWorld Group S.p.A., a company listed on the Euronext Growth Milan market (ticker S3D) and at the head of the leading Group in the sectors of industrial design and 3D printing technologies, 3D bio-manufacturing and production lines of machinery for the manufacturing of latest generation photovoltaic panels, announces that it has shipped the Electrospider platform to one of the most important hospital institutes in Lausanne, Switzerland, which will be used for oncology research and the creation of complex human tissues intended for transplants.

Electrospider, covered by a global patent, is the first multi-scale and multi-material 3D bioprinter used not only in the biomedical and oncology fields, but also in the pharmacological and cosmetic fields, for tests on replicated fabrics, and even in fashion, to create sustainable leather goods.

The President and CEO of SolidWorld Group S.p.A., Roberto Rizzo, commented “We are proud to announce that our commitment to the internationalization of the market, thanks toour revolutionary platform, has been rewarded with the shipment of this order from Lausanne. This supply marks a significant milestone in our innovation journey, offering cutting-edge solutions for the creation of implantable human tissues, oncology research and the testing of new drugs and vaccines. These activities, conducted outside the patients' bodies, exploit their cells, replicated on a digital model, maintaining conditions of body temperature, sterile environment and continuous nourishment. It is a source of great satisfaction to see this technology, completely developed in Italy, as the result of the research and innovation of some of the brightest minds in the fields of biology, biomedical engineering, information technology and aerospace".

This important milestone further strengthens SolidWorld's role as a leader in biomedical innovation, continuing with determination in its mission to offer advanced and accessible solutions for the creation of implantable human tissues and the advancement of medical research.

The effort towards international distribution of SolidWorld's exclusive technologies is currently focused on the American, Swiss and Middle Eastern countries, particularly the Persian Gulf.

***

SolidWorld Group S.p.A.is the head of a group of 10 companies active in the industrial, biomedical and solar pillars founded in the early 2000s by the engineer Roberto Rizzo. Listed since 6 July 2022 on the Euronext Growth Milan segment of the Italian Stock Exchange (ticker S3D), the Group is a leader in the development and The objective of Electrospider, in fact, is to create complex structures of entire human organs, completely changing the quality of life of patients, shortening research times (just think of the testing of a cure which, through the use of Electrospider, is now possible directly in the patient's in vitro cells) and improving the working methods of hospitals and facilities healthcare. integration of the most modern and complete 3D digital technologies, in the software and hardware fields, within manufacturing companies to support and accelerate their transformation towards Factory 5.0. Thanks to SolidWorld, all production phases of a product, up to its sale and recycling, are integrated thanks to technologies that make the production process faster, more sustainable and efficient. It operates through 16 offices and 3 technological hubs, has over 220 employees and more than 10 thousand client companies. In 2023, the acquisition of Valore BF 3d S.r.l. was completed. thanks to which SolidWorld acquired a new customer base. The transfer of a technological business unit by the company Formula E S.r.l., a company of the Vismunda S.r.l. group, a world leader in automation for equipment dedicated to the renewable energy sector which has allowed SolidWorld Group to enter the solar market, was completed in 2023. In the first half of 2024, the SolidWorld Group recorded revenues of 30.9 million euros, a production value of 40.1 million euros with an EBITDA of 6.3 million euros. www.solidworldgroup.it/en

CONTACTS
Investor Relations Manager
Elisabetta Cammarata 
investor@solidworld.it

IR & Corporate Media Advisor
TWIN
solidworld@twin.services
Federico Bagatella | T. +39 331 8007258
Morena Azzi | T.  +39 331 1070477